Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Coronary Artery Disease | 65 | 2025 | 6544 | 3.890 |
Why?
|
Coronary Angiography | 51 | 2025 | 4493 | 3.820 |
Why?
|
Plaque, Atherosclerotic | 34 | 2024 | 1529 | 3.250 |
Why?
|
Coronary Stenosis | 17 | 2024 | 800 | 2.980 |
Why?
|
Coronary Vessels | 26 | 2025 | 3096 | 2.320 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 14 | 2024 | 3251 | 1.440 |
Why?
|
HIV Infections | 41 | 2024 | 17533 | 1.350 |
Why?
|
Tomography, X-Ray Computed | 33 | 2025 | 20659 | 1.260 |
Why?
|
Chest Pain | 17 | 2023 | 1100 | 1.210 |
Why?
|
Atherosclerosis | 11 | 2024 | 3424 | 1.160 |
Why?
|
Cardiovascular Diseases | 22 | 2024 | 15652 | 1.070 |
Why?
|
Angina Pectoris | 7 | 2019 | 956 | 1.060 |
Why?
|
Acute Coronary Syndrome | 12 | 2024 | 2184 | 1.050 |
Why?
|
Quinolines | 5 | 2024 | 769 | 1.010 |
Why?
|
Fractional Flow Reserve, Myocardial | 4 | 2024 | 345 | 0.830 |
Why?
|
Risk Assessment | 35 | 2024 | 24282 | 0.790 |
Why?
|
Rehabilitation Centers | 1 | 2024 | 246 | 0.780 |
Why?
|
Predictive Value of Tests | 39 | 2024 | 15398 | 0.750 |
Why?
|
Echocardiography, Stress | 3 | 2017 | 137 | 0.700 |
Why?
|
Radiography, Thoracic | 4 | 2024 | 1315 | 0.700 |
Why?
|
Medication Therapy Management | 1 | 2020 | 131 | 0.660 |
Why?
|
Radiology Information Systems | 2 | 2014 | 532 | 0.610 |
Why?
|
Middle Aged | 105 | 2025 | 223009 | 0.600 |
Why?
|
Myocardial Perfusion Imaging | 1 | 2024 | 669 | 0.600 |
Why?
|
Risk Factors | 62 | 2025 | 74840 | 0.590 |
Why?
|
Incidental Findings | 3 | 2017 | 697 | 0.590 |
Why?
|
Musculoskeletal Diseases | 1 | 2024 | 598 | 0.580 |
Why?
|
Heart Ventricles | 6 | 2020 | 3832 | 0.570 |
Why?
|
Referral and Consultation | 2 | 2024 | 3615 | 0.560 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 9 | 2024 | 1224 | 0.550 |
Why?
|
Lung Neoplasms | 6 | 2024 | 13451 | 0.550 |
Why?
|
Pulmonary Embolism | 8 | 2020 | 2598 | 0.550 |
Why?
|
Lacrimal Apparatus | 6 | 2015 | 224 | 0.520 |
Why?
|
Solitary Pulmonary Nodule | 2 | 2017 | 276 | 0.500 |
Why?
|
Male | 108 | 2025 | 363698 | 0.490 |
Why?
|
Female | 116 | 2025 | 396112 | 0.490 |
Why?
|
Adipose Tissue | 6 | 2023 | 3312 | 0.480 |
Why?
|
Early Detection of Cancer | 5 | 2022 | 3236 | 0.460 |
Why?
|
Humans | 148 | 2025 | 765968 | 0.450 |
Why?
|
Radionuclide Imaging | 1 | 2017 | 1978 | 0.420 |
Why?
|
Angiography | 4 | 2016 | 1581 | 0.420 |
Why?
|
Lung Diseases | 2 | 2023 | 1940 | 0.420 |
Why?
|
Inpatients | 2 | 2024 | 2564 | 0.420 |
Why?
|
Asymptomatic Diseases | 6 | 2021 | 586 | 0.370 |
Why?
|
Radiography, Abdominal | 1 | 2014 | 544 | 0.360 |
Why?
|
Fee-for-Service Plans | 1 | 2016 | 716 | 0.360 |
Why?
|
Exercise Test | 4 | 2020 | 2180 | 0.360 |
Why?
|
Sjogren's Syndrome | 4 | 2015 | 239 | 0.350 |
Why?
|
Lipoproteins, LDL | 4 | 2024 | 643 | 0.350 |
Why?
|
Insulin, Long-Acting | 1 | 2010 | 59 | 0.340 |
Why?
|
Artificial Intelligence | 1 | 2024 | 2659 | 0.330 |
Why?
|
Pericardium | 3 | 2020 | 679 | 0.330 |
Why?
|
Radiation Dosage | 2 | 2017 | 1944 | 0.320 |
Why?
|
Patellar Ligament | 1 | 2009 | 65 | 0.320 |
Why?
|
Calcium | 6 | 2023 | 5767 | 0.310 |
Why?
|
Aged | 46 | 2025 | 171117 | 0.300 |
Why?
|
Dacryocystitis | 3 | 2015 | 67 | 0.300 |
Why?
|
HIV | 8 | 2023 | 1585 | 0.300 |
Why?
|
Retrospective Studies | 28 | 2025 | 81514 | 0.300 |
Why?
|
Triage | 2 | 2023 | 996 | 0.290 |
Why?
|
Prognosis | 25 | 2024 | 29922 | 0.280 |
Why?
|
Anatomy, Cross-Sectional | 1 | 2007 | 139 | 0.280 |
Why?
|
Cytomegalovirus Infections | 2 | 2024 | 836 | 0.270 |
Why?
|
Myocardial Revascularization | 3 | 2020 | 793 | 0.270 |
Why?
|
Point-of-Care Systems | 1 | 2015 | 1217 | 0.270 |
Why?
|
Cardiac Surgical Procedures | 1 | 2022 | 3675 | 0.270 |
Why?
|
Ventricular Dysfunction, Right | 2 | 2013 | 645 | 0.270 |
Why?
|
Lung | 6 | 2023 | 10033 | 0.270 |
Why?
|
Models, Cardiovascular | 3 | 2020 | 978 | 0.270 |
Why?
|
Aortic Diseases | 1 | 2012 | 729 | 0.260 |
Why?
|
Smoking | 2 | 2020 | 9081 | 0.260 |
Why?
|
Decision Support Systems, Clinical | 1 | 2015 | 1175 | 0.260 |
Why?
|
Practice Guidelines as Topic | 4 | 2020 | 7425 | 0.250 |
Why?
|
Aorta | 2 | 2017 | 2028 | 0.250 |
Why?
|
Radiographic Image Enhancement | 2 | 2007 | 872 | 0.250 |
Why?
|
Joint Diseases | 1 | 2009 | 459 | 0.250 |
Why?
|
Magnetic Resonance Angiography | 1 | 2012 | 1426 | 0.250 |
Why?
|
Guideline Adherence | 1 | 2015 | 2243 | 0.240 |
Why?
|
Coronary Care Units | 1 | 2016 | 235 | 0.240 |
Why?
|
Aortic Valve Stenosis | 3 | 2023 | 2023 | 0.240 |
Why?
|
North America | 5 | 2024 | 1285 | 0.240 |
Why?
|
Patient Transfer | 1 | 2012 | 790 | 0.240 |
Why?
|
Heart Valve Diseases | 1 | 2012 | 1030 | 0.230 |
Why?
|
Troponin I | 3 | 2022 | 655 | 0.230 |
Why?
|
Constriction, Pathologic | 4 | 2024 | 1105 | 0.220 |
Why?
|
Prospective Studies | 22 | 2024 | 54802 | 0.210 |
Why?
|
Troponin | 2 | 2024 | 533 | 0.210 |
Why?
|
Inflammation | 10 | 2024 | 10850 | 0.210 |
Why?
|
Stroke | 4 | 2023 | 9747 | 0.210 |
Why?
|
Reproducibility of Results | 15 | 2024 | 20124 | 0.210 |
Why?
|
Electrocardiography | 4 | 2019 | 6404 | 0.210 |
Why?
|
Ventricular Dysfunction, Left | 2 | 2017 | 2136 | 0.210 |
Why?
|
Hypoglycemia | 1 | 2010 | 896 | 0.200 |
Why?
|
Phosphatidylcholine-Sterol O-Acyltransferase | 1 | 2022 | 33 | 0.200 |
Why?
|
Medicare | 2 | 2022 | 6823 | 0.200 |
Why?
|
Dementia | 1 | 2017 | 2744 | 0.200 |
Why?
|
Radiography | 3 | 2023 | 6919 | 0.200 |
Why?
|
Anterior Wall Myocardial Infarction | 1 | 2022 | 42 | 0.190 |
Why?
|
Lymphoma, Follicular | 1 | 2006 | 459 | 0.190 |
Why?
|
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 1 | 2025 | 214 | 0.190 |
Why?
|
Hypertrophy, Right Ventricular | 2 | 2013 | 109 | 0.190 |
Why?
|
Hematoma | 1 | 2006 | 766 | 0.190 |
Why?
|
Proteinuria | 1 | 2024 | 607 | 0.190 |
Why?
|
Retreatment | 2 | 2014 | 598 | 0.190 |
Why?
|
Suicide, Attempted | 1 | 2010 | 1409 | 0.180 |
Why?
|
Cholesterol | 3 | 2022 | 2898 | 0.180 |
Why?
|
Adult | 38 | 2024 | 223044 | 0.180 |
Why?
|
Albuminuria | 1 | 2024 | 660 | 0.170 |
Why?
|
Journal Impact Factor | 1 | 2022 | 157 | 0.170 |
Why?
|
X-Rays | 1 | 2021 | 310 | 0.170 |
Why?
|
Amino Acids | 2 | 2018 | 1709 | 0.170 |
Why?
|
Thorax | 2 | 2023 | 554 | 0.170 |
Why?
|
Cardiac Volume | 1 | 2021 | 196 | 0.170 |
Why?
|
Fibrosis | 2 | 2018 | 2070 | 0.170 |
Why?
|
Pulmonary Edema | 1 | 2023 | 412 | 0.170 |
Why?
|
Aorta, Thoracic | 1 | 2006 | 1103 | 0.170 |
Why?
|
Spironolactone | 1 | 2023 | 415 | 0.170 |
Why?
|
Lipoprotein(a) | 1 | 2024 | 488 | 0.160 |
Why?
|
Lymphoma, B-Cell | 1 | 2006 | 943 | 0.160 |
Why?
|
Sodium-Potassium-Exchanging ATPase | 2 | 2012 | 479 | 0.160 |
Why?
|
AIDS-Associated Nephropathy | 1 | 2019 | 34 | 0.160 |
Why?
|
Double-Blind Method | 6 | 2024 | 12437 | 0.160 |
Why?
|
Sensitivity and Specificity | 5 | 2020 | 14652 | 0.150 |
Why?
|
Imaging, Three-Dimensional | 2 | 2012 | 4034 | 0.150 |
Why?
|
Fatty Liver | 1 | 2024 | 807 | 0.150 |
Why?
|
Stress, Mechanical | 2 | 2020 | 1668 | 0.150 |
Why?
|
Rupture, Spontaneous | 3 | 2018 | 359 | 0.150 |
Why?
|
Macrophages | 3 | 2024 | 5772 | 0.150 |
Why?
|
American Heart Association | 2 | 2020 | 1047 | 0.150 |
Why?
|
Nitroglycerin | 1 | 2019 | 331 | 0.150 |
Why?
|
Multiple Pulmonary Nodules | 2 | 2017 | 170 | 0.150 |
Why?
|
Elasticity | 1 | 2020 | 652 | 0.140 |
Why?
|
Cardiovascular System | 2 | 2023 | 841 | 0.140 |
Why?
|
Psoas Muscles | 1 | 2018 | 66 | 0.140 |
Why?
|
Anti-Mullerian Hormone | 1 | 2020 | 420 | 0.140 |
Why?
|
Hypoglycemic Agents | 1 | 2010 | 3110 | 0.140 |
Why?
|
Dry Eye Syndromes | 2 | 2012 | 384 | 0.140 |
Why?
|
Body Composition | 2 | 2024 | 2439 | 0.140 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2009 | 2159 | 0.140 |
Why?
|
Performance-Enhancing Substances | 1 | 2017 | 31 | 0.140 |
Why?
|
Doping in Sports | 1 | 2017 | 63 | 0.140 |
Why?
|
Testosterone Congeners | 1 | 2017 | 62 | 0.130 |
Why?
|
Weight Lifting | 1 | 2017 | 130 | 0.130 |
Why?
|
Cushing Syndrome | 1 | 2018 | 241 | 0.130 |
Why?
|
T-Lymphocyte Subsets | 1 | 2024 | 1811 | 0.130 |
Why?
|
Myocardial Infarction | 6 | 2024 | 11499 | 0.130 |
Why?
|
Severity of Illness Index | 9 | 2024 | 15880 | 0.130 |
Why?
|
Randomized Controlled Trials as Topic | 8 | 2022 | 10383 | 0.130 |
Why?
|
United States | 13 | 2023 | 72903 | 0.120 |
Why?
|
Thymus Neoplasms | 1 | 2018 | 270 | 0.120 |
Why?
|
Diabetes Mellitus | 4 | 2024 | 5891 | 0.120 |
Why?
|
Anti-HIV Agents | 4 | 2020 | 4559 | 0.120 |
Why?
|
Time Factors | 9 | 2019 | 40065 | 0.120 |
Why?
|
Aquaporin 5 | 2 | 2011 | 8 | 0.120 |
Why?
|
Purpura | 1 | 2016 | 115 | 0.120 |
Why?
|
Necrobiotic Disorders | 1 | 2014 | 5 | 0.120 |
Why?
|
Treatment Outcome | 11 | 2023 | 65188 | 0.120 |
Why?
|
Cardiac Imaging Techniques | 1 | 2017 | 280 | 0.120 |
Why?
|
Prevalence | 10 | 2024 | 15842 | 0.120 |
Why?
|
Vasodilation | 1 | 2019 | 970 | 0.120 |
Why?
|
Cranial Irradiation | 1 | 2017 | 385 | 0.120 |
Why?
|
Vasodilator Agents | 1 | 2019 | 988 | 0.120 |
Why?
|
Contrast Media | 4 | 2014 | 5329 | 0.120 |
Why?
|
Serum | 1 | 2016 | 206 | 0.120 |
Why?
|
Subcutaneous Fat | 1 | 2018 | 402 | 0.120 |
Why?
|
Utilization Review | 1 | 2016 | 381 | 0.110 |
Why?
|
Interleukin-10 | 1 | 2020 | 1183 | 0.110 |
Why?
|
Hemodynamics | 3 | 2020 | 4184 | 0.110 |
Why?
|
Mass Screening | 3 | 2022 | 5446 | 0.110 |
Why?
|
Consensus | 1 | 2024 | 3202 | 0.110 |
Why?
|
Arteritis | 1 | 2016 | 159 | 0.110 |
Why?
|
Spondylosis | 1 | 2014 | 84 | 0.110 |
Why?
|
Primary Prevention | 4 | 2024 | 1187 | 0.110 |
Why?
|
Tears | 2 | 2015 | 254 | 0.110 |
Why?
|
Adiposity | 3 | 2020 | 1890 | 0.110 |
Why?
|
Aging | 3 | 2024 | 8731 | 0.110 |
Why?
|
Aquaporin 4 | 2 | 2011 | 161 | 0.110 |
Why?
|
Cardiac-Gated Imaging Techniques | 3 | 2019 | 139 | 0.110 |
Why?
|
Comorbidity | 4 | 2018 | 10563 | 0.110 |
Why?
|
Analysis of Variance | 2 | 2012 | 6203 | 0.110 |
Why?
|
Chi-Square Distribution | 3 | 2017 | 3432 | 0.110 |
Why?
|
Cardiovascular Agents | 1 | 2020 | 851 | 0.110 |
Why?
|
Pain Measurement | 1 | 2024 | 3561 | 0.110 |
Why?
|
Periodicals as Topic | 2 | 2022 | 1462 | 0.110 |
Why?
|
Lumbosacral Region | 1 | 2014 | 295 | 0.100 |
Why?
|
Carotid Arteries | 1 | 2017 | 929 | 0.100 |
Why?
|
Coronary Artery Bypass | 1 | 2022 | 2186 | 0.100 |
Why?
|
RNA, Messenger | 6 | 2015 | 12768 | 0.100 |
Why?
|
Aortic Valve | 3 | 2023 | 1968 | 0.100 |
Why?
|
Intra-Abdominal Fat | 1 | 2018 | 623 | 0.100 |
Why?
|
Length of Stay | 2 | 2024 | 6485 | 0.100 |
Why?
|
Sex Factors | 4 | 2020 | 10603 | 0.100 |
Why?
|
Dyspnea | 2 | 2017 | 1352 | 0.100 |
Why?
|
Diagnosis, Differential | 7 | 2018 | 12976 | 0.100 |
Why?
|
Claudins | 1 | 2013 | 118 | 0.100 |
Why?
|
Menopause | 1 | 2020 | 1659 | 0.100 |
Why?
|
Magnetic Resonance Imaging | 3 | 2024 | 36532 | 0.100 |
Why?
|
Pregnancy, Animal | 1 | 2012 | 124 | 0.100 |
Why?
|
Acute Disease | 5 | 2017 | 7232 | 0.100 |
Why?
|
Rabbits | 6 | 2015 | 4734 | 0.100 |
Why?
|
Ischemic Attack, Transient | 1 | 2017 | 870 | 0.100 |
Why?
|
Registries | 5 | 2018 | 8297 | 0.100 |
Why?
|
Neuroendocrine Tumors | 1 | 2018 | 654 | 0.090 |
Why?
|
Cholesterol, LDL | 4 | 2024 | 2393 | 0.090 |
Why?
|
Multivariate Analysis | 4 | 2017 | 12056 | 0.090 |
Why?
|
Papillomaviridae | 1 | 2017 | 1141 | 0.090 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 6 | 2015 | 4562 | 0.090 |
Why?
|
Carotid Artery Diseases | 1 | 2017 | 874 | 0.090 |
Why?
|
Venous Thrombosis | 1 | 2020 | 1327 | 0.090 |
Why?
|
Dilatation, Pathologic | 1 | 2012 | 527 | 0.090 |
Why?
|
Blotting, Western | 6 | 2015 | 5020 | 0.090 |
Why?
|
Chloride Channels | 1 | 2012 | 221 | 0.090 |
Why?
|
Cohort Studies | 8 | 2023 | 41649 | 0.090 |
Why?
|
Decision Support Techniques | 1 | 2020 | 2003 | 0.090 |
Why?
|
Tight Junctions | 1 | 2013 | 330 | 0.090 |
Why?
|
Aquaporins | 1 | 2011 | 176 | 0.090 |
Why?
|
Mortality | 1 | 2021 | 2904 | 0.090 |
Why?
|
Thoracic Vertebrae | 1 | 2014 | 614 | 0.080 |
Why?
|
ROC Curve | 3 | 2019 | 3620 | 0.080 |
Why?
|
Disease Progression | 4 | 2020 | 13632 | 0.080 |
Why?
|
Androgens | 1 | 2017 | 1279 | 0.080 |
Why?
|
Emergency Service, Hospital | 3 | 2018 | 7875 | 0.080 |
Why?
|
Vaccination | 1 | 2022 | 3426 | 0.080 |
Why?
|
Hydrodynamics | 2 | 2020 | 163 | 0.080 |
Why?
|
Multicenter Studies as Topic | 3 | 2019 | 1731 | 0.080 |
Why?
|
Vitamin D Deficiency | 1 | 2019 | 1348 | 0.080 |
Why?
|
Tricuspid Valve | 1 | 2012 | 422 | 0.080 |
Why?
|
Gadolinium DTPA | 1 | 2012 | 823 | 0.080 |
Why?
|
Cytomegalovirus | 2 | 2024 | 751 | 0.080 |
Why?
|
Heart | 2 | 2023 | 4414 | 0.080 |
Why?
|
Anticholesteremic Agents | 1 | 2016 | 970 | 0.080 |
Why?
|
Anti-Retroviral Agents | 1 | 2018 | 1787 | 0.080 |
Why?
|
Patient Readmission | 2 | 2023 | 3286 | 0.080 |
Why?
|
Amyloidosis | 1 | 2016 | 885 | 0.070 |
Why?
|
Aged, 80 and over | 9 | 2024 | 59489 | 0.070 |
Why?
|
Protein Subunits | 1 | 2011 | 939 | 0.070 |
Why?
|
Algorithms | 2 | 2010 | 14071 | 0.070 |
Why?
|
Heart Diseases | 1 | 2021 | 2821 | 0.070 |
Why?
|
Longitudinal Studies | 2 | 2022 | 14751 | 0.070 |
Why?
|
Spine | 1 | 2014 | 1128 | 0.070 |
Why?
|
Young Adult | 9 | 2021 | 59889 | 0.070 |
Why?
|
Venous Thromboembolism | 1 | 2020 | 1882 | 0.070 |
Why?
|
Fluorescent Antibody Technique | 4 | 2012 | 2476 | 0.070 |
Why?
|
Monocytes | 1 | 2016 | 2595 | 0.070 |
Why?
|
Cell Adhesion Molecules | 1 | 2013 | 1612 | 0.070 |
Why?
|
Placebos | 2 | 2024 | 1659 | 0.070 |
Why?
|
Liver | 2 | 2021 | 7562 | 0.060 |
Why?
|
Viral Load | 3 | 2022 | 3386 | 0.060 |
Why?
|
Bone Marrow | 1 | 2016 | 2921 | 0.060 |
Why?
|
Papillomavirus Infections | 1 | 2017 | 1640 | 0.060 |
Why?
|
HIV-1 | 2 | 2020 | 6944 | 0.060 |
Why?
|
Biomedical Research | 1 | 2021 | 3458 | 0.060 |
Why?
|
Electronic Health Records | 1 | 2022 | 4873 | 0.060 |
Why?
|
Logistic Models | 3 | 2017 | 13266 | 0.060 |
Why?
|
Cross-Sectional Studies | 6 | 2024 | 26318 | 0.060 |
Why?
|
Vitamin D | 1 | 2019 | 3272 | 0.060 |
Why?
|
Antigens, Neoplasm | 1 | 2013 | 2002 | 0.060 |
Why?
|
Observer Variation | 3 | 2018 | 2615 | 0.060 |
Why?
|
Research Design | 1 | 2020 | 6209 | 0.060 |
Why?
|
Clinical Trials, Phase III as Topic | 2 | 2019 | 878 | 0.060 |
Why?
|
Ventricular Function, Left | 1 | 2017 | 3928 | 0.060 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2021 | 8923 | 0.060 |
Why?
|
Decision Making | 1 | 2018 | 3965 | 0.060 |
Why?
|
Gene Expression Regulation | 2 | 2012 | 11888 | 0.060 |
Why?
|
Automation | 2 | 2017 | 585 | 0.050 |
Why?
|
Axilla | 1 | 2006 | 615 | 0.050 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2018 | 3247 | 0.050 |
Why?
|
Clinical Trials as Topic | 1 | 2019 | 8041 | 0.050 |
Why?
|
Disease-Free Survival | 3 | 2018 | 6832 | 0.050 |
Why?
|
Head and Neck Neoplasms | 1 | 2017 | 2921 | 0.050 |
Why?
|
RNA, Viral | 2 | 2023 | 2864 | 0.050 |
Why?
|
Comparative Effectiveness Research | 2 | 2019 | 714 | 0.050 |
Why?
|
Antibodies, Antineutrophil Cytoplasmic | 1 | 2025 | 283 | 0.050 |
Why?
|
Lecithins | 1 | 2022 | 16 | 0.050 |
Why?
|
Fluorodeoxyglucose F18 | 2 | 2014 | 2024 | 0.050 |
Why?
|
Kaplan-Meier Estimate | 3 | 2017 | 6499 | 0.050 |
Why?
|
Sterol O-Acyltransferase | 1 | 2022 | 28 | 0.050 |
Why?
|
Survival Rate | 2 | 2018 | 12795 | 0.050 |
Why?
|
Radiopharmaceuticals | 2 | 2017 | 2699 | 0.050 |
Why?
|
Whole Body Imaging | 1 | 2024 | 281 | 0.050 |
Why?
|
1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 2023 | 127 | 0.050 |
Why?
|
Pulmonary Artery | 1 | 2011 | 1935 | 0.050 |
Why?
|
Nucleosides | 1 | 2022 | 130 | 0.050 |
Why?
|
Crohn Disease | 1 | 2014 | 2283 | 0.050 |
Why?
|
Skin | 1 | 2016 | 4489 | 0.050 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2017 | 4044 | 0.050 |
Why?
|
Information Storage and Retrieval | 1 | 2007 | 834 | 0.050 |
Why?
|
Immunoglobulin G | 2 | 2024 | 4528 | 0.050 |
Why?
|
Abdominal Muscles | 1 | 2022 | 172 | 0.050 |
Why?
|
Ultrasonography, Interventional | 2 | 2020 | 1531 | 0.050 |
Why?
|
Lymph Nodes | 2 | 2017 | 3454 | 0.040 |
Why?
|
User-Computer Interface | 1 | 2007 | 1405 | 0.040 |
Why?
|
Accidents, Traffic | 1 | 2006 | 818 | 0.040 |
Why?
|
Substance-Related Disorders | 1 | 2017 | 4416 | 0.040 |
Why?
|
Heart Failure | 3 | 2023 | 11840 | 0.040 |
Why?
|
Respiration, Artificial | 2 | 2023 | 2709 | 0.040 |
Why?
|
Interleukin-6 | 2 | 2022 | 3222 | 0.040 |
Why?
|
Integrases | 1 | 2022 | 520 | 0.040 |
Why?
|
Medical Informatics | 1 | 2007 | 745 | 0.040 |
Why?
|
Publishing | 1 | 2007 | 835 | 0.040 |
Why?
|
Hyperlipoproteinemia Type II | 1 | 2025 | 394 | 0.040 |
Why?
|
Case-Control Studies | 4 | 2019 | 22223 | 0.040 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2012 | 3356 | 0.040 |
Why?
|
Adolescent | 7 | 2019 | 88835 | 0.040 |
Why?
|
Administration, Sublingual | 1 | 2019 | 60 | 0.040 |
Why?
|
Shear Strength | 1 | 2020 | 160 | 0.040 |
Why?
|
Reverse Transcriptase Inhibitors | 1 | 2022 | 618 | 0.040 |
Why?
|
Muscles | 1 | 2024 | 1578 | 0.040 |
Why?
|
Arteries | 1 | 2024 | 1118 | 0.040 |
Why?
|
Interleukin-18 | 1 | 2021 | 251 | 0.040 |
Why?
|
Transdermal Patch | 1 | 2019 | 51 | 0.040 |
Why?
|
Follow-Up Studies | 4 | 2023 | 39193 | 0.040 |
Why?
|
Information Dissemination | 1 | 2007 | 1142 | 0.040 |
Why?
|
Tablets | 1 | 2019 | 149 | 0.040 |
Why?
|
Edema | 1 | 2023 | 760 | 0.040 |
Why?
|
Perfusion | 1 | 2023 | 1407 | 0.040 |
Why?
|
Proportional Hazards Models | 3 | 2017 | 12509 | 0.040 |
Why?
|
Respiratory Sounds | 1 | 2023 | 705 | 0.040 |
Why?
|
Glucose | 1 | 2010 | 4335 | 0.040 |
Why?
|
Hypertension | 1 | 2018 | 8626 | 0.040 |
Why?
|
Child, Preschool | 1 | 2021 | 42500 | 0.040 |
Why?
|
Alanine Transaminase | 1 | 2021 | 607 | 0.040 |
Why?
|
Lipoproteins, HDL | 1 | 2022 | 674 | 0.040 |
Why?
|
Platelet Count | 1 | 2020 | 782 | 0.040 |
Why?
|
Multiple Myeloma | 1 | 2016 | 5197 | 0.040 |
Why?
|
Pregnancy Complications | 1 | 2011 | 2975 | 0.040 |
Why?
|
Finite Element Analysis | 1 | 2020 | 440 | 0.040 |
Why?
|
Technetium Tc 99m Pentetate | 1 | 2017 | 67 | 0.030 |
Why?
|
Epithelial Cells | 3 | 2015 | 3681 | 0.030 |
Why?
|
Receptors, Interleukin-1 | 1 | 2018 | 260 | 0.030 |
Why?
|
Mannans | 1 | 2017 | 57 | 0.030 |
Why?
|
Markov Chains | 1 | 2020 | 968 | 0.030 |
Why?
|
Administration, Cutaneous | 1 | 2019 | 715 | 0.030 |
Why?
|
Mannose-Binding Lectins | 1 | 2017 | 100 | 0.030 |
Why?
|
Tomography, X-Ray | 1 | 2016 | 58 | 0.030 |
Why?
|
Growth Differentiation Factor 15 | 1 | 2018 | 198 | 0.030 |
Why?
|
Aerosols | 1 | 2019 | 633 | 0.030 |
Why?
|
Disease Models, Animal | 5 | 2015 | 18293 | 0.030 |
Why?
|
Adrenocorticotropic Hormone | 1 | 2018 | 616 | 0.030 |
Why?
|
Galectin 3 | 1 | 2018 | 238 | 0.030 |
Why?
|
Confusion | 1 | 2018 | 277 | 0.030 |
Why?
|
Purpura Fulminans | 1 | 2016 | 21 | 0.030 |
Why?
|
Reproduction | 1 | 2020 | 641 | 0.030 |
Why?
|
Muscle Cells | 1 | 2016 | 194 | 0.030 |
Why?
|
Obesity | 1 | 2018 | 13076 | 0.030 |
Why?
|
Adrenal Glands | 1 | 2018 | 558 | 0.030 |
Why?
|
Cardiomegaly | 1 | 2018 | 589 | 0.030 |
Why?
|
Positron-Emission Tomography | 2 | 2014 | 6547 | 0.030 |
Why?
|
Odds Ratio | 2 | 2017 | 9649 | 0.030 |
Why?
|
Galectins | 1 | 2018 | 294 | 0.030 |
Why?
|
Dextrans | 1 | 2017 | 571 | 0.030 |
Why?
|
Internet | 1 | 2007 | 3106 | 0.030 |
Why?
|
Heart Valve Prosthesis | 1 | 2023 | 1466 | 0.030 |
Why?
|
Systole | 1 | 2017 | 935 | 0.030 |
Why?
|
Tomography, Emission-Computed | 1 | 2017 | 1006 | 0.030 |
Why?
|
Diastole | 1 | 2017 | 785 | 0.030 |
Why?
|
Coronary Circulation | 1 | 2020 | 1602 | 0.030 |
Why?
|
Echocardiography | 2 | 2017 | 5045 | 0.030 |
Why?
|
Lectins, C-Type | 1 | 2017 | 592 | 0.030 |
Why?
|
Radiology | 1 | 2007 | 2090 | 0.030 |
Why?
|
Academic Medical Centers | 1 | 2024 | 2780 | 0.030 |
Why?
|
Risk Adjustment | 1 | 2017 | 596 | 0.030 |
Why?
|
Phenotype | 2 | 2022 | 16721 | 0.030 |
Why?
|
Angina, Unstable | 1 | 2017 | 893 | 0.030 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2023 | 1566 | 0.030 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2019 | 1061 | 0.030 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2019 | 1514 | 0.030 |
Why?
|
Blood Proteins | 1 | 2018 | 1188 | 0.030 |
Why?
|
Cardiology | 1 | 2024 | 1702 | 0.030 |
Why?
|
Pleural Effusion | 1 | 2016 | 346 | 0.030 |
Why?
|
Antibodies, Viral | 1 | 2024 | 3211 | 0.030 |
Why?
|
Body Mass Index | 2 | 2022 | 13039 | 0.020 |
Why?
|
Host-Pathogen Interactions | 1 | 2021 | 1461 | 0.020 |
Why?
|
Sex Characteristics | 1 | 2023 | 2643 | 0.020 |
Why?
|
Minority Groups | 1 | 2019 | 1207 | 0.020 |
Why?
|
Caco-2 Cells | 1 | 2013 | 366 | 0.020 |
Why?
|
Software | 2 | 2017 | 4462 | 0.020 |
Why?
|
Boston | 2 | 2018 | 9338 | 0.020 |
Why?
|
Hospitalization | 3 | 2017 | 10808 | 0.020 |
Why?
|
Sodium-Potassium-Chloride Symporters | 1 | 2012 | 105 | 0.020 |
Why?
|
Eye Proteins | 1 | 2015 | 628 | 0.020 |
Why?
|
Spleen | 1 | 2017 | 2296 | 0.020 |
Why?
|
Stroke Volume | 2 | 2017 | 5596 | 0.020 |
Why?
|
Area Under Curve | 1 | 2015 | 1638 | 0.020 |
Why?
|
Fatal Outcome | 1 | 2016 | 1831 | 0.020 |
Why?
|
Exanthema | 1 | 2016 | 502 | 0.020 |
Why?
|
Rose Bengal | 1 | 2011 | 115 | 0.020 |
Why?
|
Fatigue | 1 | 2018 | 1549 | 0.020 |
Why?
|
Disease Susceptibility | 1 | 2018 | 1789 | 0.020 |
Why?
|
Outpatients | 1 | 2019 | 1595 | 0.020 |
Why?
|
Pregnancy | 4 | 2015 | 30260 | 0.020 |
Why?
|
Residence Characteristics | 1 | 2020 | 2116 | 0.020 |
Why?
|
Ventricular Remodeling | 1 | 2018 | 1272 | 0.020 |
Why?
|
CD4 Lymphocyte Count | 1 | 2016 | 2587 | 0.020 |
Why?
|
Glomerular Filtration Rate | 1 | 2019 | 2233 | 0.020 |
Why?
|
Animals | 7 | 2020 | 168764 | 0.020 |
Why?
|
Autoimmune Diseases | 2 | 2012 | 2226 | 0.020 |
Why?
|
Monitoring, Physiologic | 1 | 2017 | 1792 | 0.020 |
Why?
|
Proteomics | 1 | 2022 | 3910 | 0.020 |
Why?
|
Gene Expression | 2 | 2011 | 7584 | 0.020 |
Why?
|
Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2012 | 452 | 0.020 |
Why?
|
Genomics | 1 | 2025 | 5929 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 2020 | 3850 | 0.020 |
Why?
|
Models, Theoretical | 1 | 2020 | 3564 | 0.020 |
Why?
|
Ventricular Function, Right | 1 | 2013 | 629 | 0.020 |
Why?
|
Muscle, Skeletal | 1 | 2023 | 4958 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2013 | 1599 | 0.020 |
Why?
|
Communication | 1 | 2022 | 3916 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2019 | 5302 | 0.020 |
Why?
|
Word Processing | 1 | 2007 | 7 | 0.020 |
Why?
|
Receptors, Cell Surface | 1 | 2017 | 2817 | 0.020 |
Why?
|
Cost-Benefit Analysis | 1 | 2020 | 5526 | 0.020 |
Why?
|
Regression Analysis | 1 | 2017 | 6322 | 0.020 |
Why?
|
Tomography, Optical Coherence | 1 | 2020 | 2932 | 0.020 |
Why?
|
Myocardial Ischemia | 1 | 2018 | 2128 | 0.020 |
Why?
|
Cell Adhesion | 1 | 2013 | 3089 | 0.020 |
Why?
|
Spinal Fusion | 1 | 2014 | 1302 | 0.010 |
Why?
|
Transfection | 1 | 2013 | 5743 | 0.010 |
Why?
|
Microscopy, Confocal | 1 | 2011 | 1966 | 0.010 |
Why?
|
Health Status | 1 | 2018 | 4080 | 0.010 |
Why?
|
Patient Selection | 1 | 2017 | 4255 | 0.010 |
Why?
|
Orthopedic Procedures | 1 | 2014 | 1280 | 0.010 |
Why?
|
Brain Ischemia | 1 | 2017 | 3000 | 0.010 |
Why?
|
Cornea | 1 | 2011 | 1316 | 0.010 |
Why?
|
Wounds and Injuries | 1 | 2016 | 2511 | 0.010 |
Why?
|
Databases, Factual | 1 | 2017 | 8067 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2023 | 15747 | 0.010 |
Why?
|
Cooperative Behavior | 1 | 2007 | 1509 | 0.010 |
Why?
|
Incidence | 1 | 2017 | 21480 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2012 | 11022 | 0.010 |
Why?
|
Child | 1 | 2014 | 80564 | 0.000 |
Why?
|